A 1H NMR study of the oligonucleotide binding of [(en)Pt(mu-dpzm)2Pt(en)]Cl4.
The non-covalent binding of [(en)Pt(mu-dpzm)2Pt(en)]4+ to the dodecanucleotides d(CGCGAATTCGCG)2 and d(CAATCCGGATTG)2 has been studied by 1H NMR spectroscopy in order to gain a greater understanding of the pre-covalent binding association of cationic dinuclear platinum(II) anti-cancer drugs. NOESY experiments showed that the metal complex bound in the minor groove at the A/T rich regions of both dodecanucleotides. The metal complex did not induce any major DNA conformational changes. However, given the relative dimensions of the DNA minor groove and the metal complex, it is reasonable to expect that the metal complex binding significantly widens the minor groove at the A/T rich binding sites. The results of this study suggest that although dinuclear platinum(II) anti-cancer drugs covalently bind at GC sequences in the DNA major groove, they will preferentially associate with AT sequences in the minor groove before the covalent binding.
Wheate
N J
NJ
School of Chemistry, University College, University of New South Wales, Australian Defence Force Academy, Canberra.
Collins
J G
JG
D004247:DNA / Q000737:chemistry / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008956:Models, Chemical; D009690:Nucleic Acid Conformation; D009841:Oligonucleotides / Q000378:metabolism*; D009944:Organoplatinum Compounds / Q000737:chemistry* / Q000378:metabolism*; D010984:Platinum / Q000737:chemistry / Q000378:metabolism; D011720:Pyrazoles / Q000737:chemistry* / Q000378:metabolism*
D009841:Oligonucleotides; D009944:Organoplatinum Compounds; D011720:Pyrazoles; C415338:bis(4,4-dipyrazolylmethane-N,N')-bis(ethylenediamineplatinum(II)); D010984:Platinum; D004247:DNA